To print: Select File and then Print from your browser's menu

Title: Epithelial Barrier Function Remains Intact Following Topical Latanoprost for Glaucoma

URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&list_uids=12424402&dopt=Abstract

Ophthalmologica 2002 Sep-Oct;216(5):351-4. "Influence of Latanoprost on the Corneal Epithelial Barrier Function in Glaucoma Patients."
11/18/2002 03:46:10 PM
By Mark Moran

The corneal epithelial barrier function appears to remain intact following administration of topical latanoprost for glaucoma. Researchers at the Kyoto Prerfectural University of Medicine, Kyoto, Japan, evaluated the influence of topically administered latanoprost on corneal epithelial barrier function in 10 patients with no prior topical antiglaucoma medication and 14 patients already receiving medication. The 10 treatment-naïve patients received topical latanoprost (0.005%) once daily for 30 days, while the 14 patients receiving combination therapy were given the same dose once daily for 180 days. Corneal epithelial barrier function was measured before and after treatment in each group with a fluorophotometric technique. The mean fluorescein uptakes in the monotherapy group were 54.6 ng/ml and 57.1 ng/ml before and 30 days after treatment, respectively (p = 0.81). In the combination group, the mean uptakes were 101.0 ng/ml before treatment, 118.9 ng/ml after 30 days of treatment (p = 0.38) and 93.4 ng/ml (p = 0.58) after 180 of treatment.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&list_uids=12424402&dopt=Abstract

Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.